Mehdi BRAHMI
Centre Leon Berard · Centre Léon Bérard, Lyon
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mehdi BRAHMI as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:22 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05152472 · A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard TreatmentsCentre Leon Berard · active not recruiting · Unresectable Gastrointestinal Stromal Tumor (GIST), Locally Advanced Gastrointestinal Stromal Tumor (GIST), Metastatic Gastrointestinal Stromal Tumor · principal investigator
- N/ANCT04927260 · French Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST PatientsCentre Leon Berard · unknown · GIST, GIST, Malignant, PDGFR-Alpha D842V · principal investigator
- Ph2NCT04698785 · Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas PatientsCentre Leon Berard · recruiting · Bone Sarcoma, Osteosarcoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:22 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:22 UTC. The ranking covers the 200 most relevant of 14 PubMed records, and a shared surname and initials can bring in a namesake. All 14 on PubMed
- Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial.Lancet Oncol · 202389 citationsRCR 7.4
- Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study.J Clin Oncol · 202184 citationsRCR 4.1
- CRYODESMO-O1: A prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment.Eur J Cancer · 202183 citationsRCR 6.8
- A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse.Ann Oncol · 202453 citationsRCR 7.7
- 28 citationsRCR 3.5
- 24 citationsRCR 1.0
- 16 citationsRCR 0.9
- Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial.Nat Med · 202514 citationsRCR 2.5
- 6 citationsRCR 1.5
- 5 citationsRCR 0.2